Skip main navigation
Close Drawer MenuOpen Drawer Menu
APA Publishing Logo

The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Back to table of contents
Med CheckFull Access

Medication Names and Manufacturers

Published Online:20 Jun 2003https://doi.org/10.1176/pn.38.12.0019a

The following medications were cited in this issue’s Med Check feature. The generic name is followed by the brand name and manufacturer.

• Aripiprazole: Abilify (Bristol-Myers Squibb/Otsuka)

• Atomoxetine: Strattera (Lilly)

• Carbamazepine extended release: Carbitrol (Shire)

• Duloxetine: Cymbalta (Lilly; pending FDA approval)

• Escitalopram: Lexapro (Forest Laboratories)

• Lamotrigine: Lamictal (GlaxoSmithKline)

• Olanzapine: Zyprexa (Lilly)

• Oxcarbazepine: Trileptal (Novartis)

• Paroxetine: Paxil (GlaxoSmithKline)

• Quetiapine: Seroquel (AstraZeneca)

• Risperidone: Risperdal (Janssen)

• Risperidone long acting: Risperdal Consta (Janssen; pending FDA approval)

• Tamoxifen: Nolvadex (AstraZeneca)

• Valproate: Depakote (Abbott Laboratories)

• Ziprasidone: Geodon (Pfizer)